Skip to main content

Advertisement

ADVERTISEMENT

Conference Coverage

Genetic Immunogenicity Factor Appears In Hispanic- and European-Descent Patients
Conference Coverage
10/29/2020
The human leukocyte antigen variant that causes patients to develop antibodies to anti-tumor necrosis factor therapeutics is fairly common in patients of European and Hispanic descent, but seems not to cause immunogenicity to other biologics,...
The human leukocyte antigen variant that causes patients to develop antibodies to anti-tumor necrosis factor therapeutics is fairly common in patients of European and Hispanic descent, but seems not to cause immunogenicity to other biologics,...
The human leukocyte antigen...
10/29/2020
Advances in Inflammatory Bowel Disease Network

Advertisement

Pouch Failure Has Rapid Progression Among Children With UC
Conference Coverage
10/29/2020
An award-winning poster from the American College of Gastroenterology 2020 clinical meeting examined the outcomes of children who have ileal-pouch anal-anastamosis surgery for treatment of ulcerative colitis.
An award-winning poster from the American College of Gastroenterology 2020 clinical meeting examined the outcomes of children who have ileal-pouch anal-anastamosis surgery for treatment of ulcerative colitis.
An award-winning poster from the...
10/29/2020
Advances in Inflammatory Bowel Disease Network
Optimization of Treatment for IBD
Conference Coverage
09/12/2020
David A. Schwartz, MD, presented his approach to optimizing therapy for patients with IBD to induce remission and achieve mucosal healing.
David A. Schwartz, MD, presented his approach to optimizing therapy for patients with IBD to induce remission and achieve mucosal healing.
David A. Schwartz, MD, presented...
09/12/2020
Advances in Inflammatory Bowel Disease Network
No COVID-19 Deaths Reported in Patients With IBD in Los Angeles
Conference Coverage
08/27/2020
In a regional update on the pandemic, Gil Melmed, MD, and Christina Ha, MD, from Cedars-Sinai Medical Center in Los Angeles reviewed the impact of COVID-19 on patients with inflammatory bowel disease and the challenges of treatment.
In a regional update on the pandemic, Gil Melmed, MD, and Christina Ha, MD, from Cedars-Sinai Medical Center in Los Angeles reviewed the impact of COVID-19 on patients with inflammatory bowel disease and the challenges of treatment.
In a regional update on the...
08/27/2020
Advances in Inflammatory Bowel Disease Network

Advertisement

Is Precision Medicine for IBD Ready for Prime Time?
Conference Coverage
08/25/2020
What exactly is precision medicine, and is it ready to be applied in gastroenterology practice? Millie Long, MD, discussed the topic at the virtual Advances in Inflammatory Bowel Disease regional meeting on August 22.
What exactly is precision medicine, and is it ready to be applied in gastroenterology practice? Millie Long, MD, discussed the topic at the virtual Advances in Inflammatory Bowel Disease regional meeting on August 22.
What exactly is precision...
08/25/2020
Advances in Inflammatory Bowel Disease Network
Treat-To-Target Approach for Inflammatory Bowel Disease
Conference Coverage
08/22/2020
Applying a systematic treat-to-target approach is effective for reducing the risk of long-term complications in patients with IBD, but incremental benefit must be evaluated. Siddarth Singh, MD, spoke about this topic at today’s AIBD 2020...
Applying a systematic treat-to-target approach is effective for reducing the risk of long-term complications in patients with IBD, but incremental benefit must be evaluated. Siddarth Singh, MD, spoke about this topic at today’s AIBD 2020...
Applying a systematic...
08/22/2020
Advances in Inflammatory Bowel Disease Network
Diagnosing and Managing C difficile Infection in Patients With IBD
Conference Coverage
07/29/2020
Even among patients without pre-existing gastrointestinal disease, Clostridioides difficile is often debilitating. In patients with inflammatory bowel disease, it can be very serious. Jessica Allegretti, MD, explained the steps to diagnosing...
Even among patients without pre-existing gastrointestinal disease, Clostridioides difficile is often debilitating. In patients with inflammatory bowel disease, it can be very serious. Jessica Allegretti, MD, explained the steps to diagnosing...
Even among patients without...
07/29/2020
Advances in Inflammatory Bowel Disease Network

Advertisement

Positioning Biosimilars as First-Line or Switch Therapy
Conference Coverage
07/25/2020
Biosimilars can reduce costs in treating inflammatory bowel disease, but are they really as effective and safe? Raymond Cross, MD, related his experience in working with these therapies at the virtual Advances in Inflammatory Bowel Disease...
Biosimilars can reduce costs in treating inflammatory bowel disease, but are they really as effective and safe? Raymond Cross, MD, related his experience in working with these therapies at the virtual Advances in Inflammatory Bowel Disease...
Biosimilars can reduce costs in...
07/25/2020
Advances in Inflammatory Bowel Disease Network
COVID-19, IBD, and Telemedicine
Conference Coverage
07/24/2020
Miguel Regueiro, MD, reviewed how COVID-19 has affected the practice of gastroenterology and the role of telemedicine in negotiating the pandemic at the Advances in Inflammatory Bowel Diseases 2020 virtual regional meeting on July 25.
Miguel Regueiro, MD, reviewed how COVID-19 has affected the practice of gastroenterology and the role of telemedicine in negotiating the pandemic at the Advances in Inflammatory Bowel Diseases 2020 virtual regional meeting on July 25.
Miguel Regueiro, MD, reviewed...
07/24/2020
Advances in Inflammatory Bowel Disease Network
Positioning Therapeutic Agents for IBD
Conference Coverage
07/24/2020
The many different classes of medications available for treating inflammatory bowel disease give gastroenterologists more options than ever before—and also more challenges in determining how to balance efficacy and safety. Miguel Regueiro,...
The many different classes of medications available for treating inflammatory bowel disease give gastroenterologists more options than ever before—and also more challenges in determining how to balance efficacy and safety. Miguel Regueiro,...
The many different classes of...
07/24/2020
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement